Literature DB >> 22321281

[Resveratrol improves coronary collateral circulation in pigs with experimental acute coronary occlusion].

Zhi-rong Wang1, Wu Xu, Chao-qun Zhang, Wei Xie, Zhao-feng Zhou, Xiao-feng Zhou, Zhuo-qi Zhang.   

Abstract

OBJECTIVE: To evaluate the impact of resveratrol on coronary collateral circulation in pigs suffered from experimental acute coronary occlusion.
METHODS: Eighteen healthy pigs were randomly divided into 3 groups: resveratrol group, nitroglycerin group and control group. Animal model of acute coronary occlusion was established through PTCA method, and the blood flow spectrum in the left circumflex artery (LCX) was detected using intracoronary Doppler ultrasound.
RESULTS: The average peak velocity (APV) in infarction correlation artery (IRA) was significantly decreased immediately after coronary occlusion [(0.85 ± 0.25) cm/s vs. (24.83 ± 3.43) cm/s, P < 0.05]. The APV remained unchanged during 0, 30 and 60 minutes after the occlusion. Reversed or bidirectional blood flow was observed and the APV increased significantly [(9.22 ± 0.80) cm/s vs. (0.84 ± 0.21) cm/s, (8.93 ± 1.28) cm/s vs. (0.86 ± 0.26) cm/s respectively, P < 0.05] after the coronary injection of resveratrol (2 mg) or nitroglycerin (0.3 mg). There was no significant difference in peak APV between the resveratrol and nitroglycerin groups. The duration of increased APV was significantly longer in resveratrol group than that in nitroglycerin group [(58.83 ± 6.15) min vs. (21.80 ± 5.79) min, P < 0.05].
CONCLUSIONS: The collateral circulation after acute coronary occlusion was obviously insufficient in pigs. Resveratrol could significantly improve the blood flow in coronary collateral circulation after acute occlusion in this model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22321281

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  1 in total

1.  Effects of resveratrol in pregnancy using murine models with reduced blood supply to the uterus.

Authors:  Rajan Poudel; Joanna L Stanley; Christian F Rueda-Clausen; Irene J Andersson; Colin P Sibley; Sandra T Davidge; Philip N Baker
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.